Inogen (INGN) Set to Post Quarterly Earnings on Thursday

by · The Markets Daily

Inogen (NASDAQ:INGN – Get Free Report) is expected to be announcing its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect the company to post earnings of ($0.11) per share and revenue of $92.25 million for the quarter. Investors can check the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, November 5, 2026 at 5:00 PM ET.

Inogen (NASDAQ:INGN – Get Free Report) last announced its earnings results on Thursday, August 6th. The medical technology company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.01. The firm had revenue of $95.08 million during the quarter, compared to the consensus estimate of $95.23 million. Inogen had a negative net margin of 6.94% and a negative return on equity of 13.17%.

Inogen Stock Performance

NASDAQ:INGN opened at $7.02 on Wednesday. The company’s 50-day moving average is $5.89 and its two-hundred day moving average is $6.22. Inogen has a 12-month low of $5.05 and a 12-month high of $8.29.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Inogen in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Inogen presently has an average rating of “Moderate Buy”.

View Our Latest Research Report on INGN

About Inogen

(Get Free Report)

Inogen, Inc is a medical technology company that develops, manufactures and markets portable oxygen concentrators for people who require long-term supplemental oxygen therapy. Its devices separate oxygen from ambient air and deliver concentrated oxygen without the need for traditional compressed-gas or liquid-oxygen tanks.

The company’s product portfolio has included the Inogen One portable oxygen concentrator line, as well as stationary and related oxygen therapy products. These systems are designed to support mobility and independence for patients with chronic respiratory conditions while offering features such as rechargeable batteries, portability and various oxygen-delivery settings.

Founded in 2001 and headquartered in Goleta, California, Inogen sells its products through direct-to-consumer channels, health-care providers, distributors and other commercial partners.

Further Reading